Corradi M, Luechtefeld T, de Haan A, Pieters R, Freedman J, Vanhaecke T
Front Toxicol. 2024; 6:1393662.
PMID: 38800806
PMC: 11116573.
DOI: 10.3389/ftox.2024.1393662.
Aslamkhan A, Michna L, Podtelezhnikov A, Vlasakova K, Suemizu H, Ohnishi Y
Toxicol Res (Camb). 2024; 13(1):tfad120.
PMID: 38223529
PMC: 10784659.
DOI: 10.1093/toxres/tfad120.
Mihajlovic M, Vinken M
Int J Mol Sci. 2022; 23(6).
PMID: 35328737
PMC: 8951158.
DOI: 10.3390/ijms23063315.
Williams D
Philos Trans R Soc Lond B Biol Sci. 2018; 373(1750).
PMID: 29786562
PMC: 5974450.
DOI: 10.1098/rstb.2017.0228.
Shen W, De Hoyos C, Sun H, Vickers T, Liang X, Crooke S
Nucleic Acids Res. 2018; 46(5):2204-2217.
PMID: 29390093
PMC: 5861398.
DOI: 10.1093/nar/gky060.
Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
Dragovic S, Vermeulen N, Gerets H, Hewitt P, Ingelman-Sundberg M, Park B
Arch Toxicol. 2016; 90(12):2979-3003.
PMID: 27659300
PMC: 5104805.
DOI: 10.1007/s00204-016-1845-1.
Evaluation of mitochondrial toxicity in Marmota himalayana treated with metacavir, a novel 2',3'-dideoxyguanosine prodrug for treatment of hepatitis B Virus.
Zhang P, Zhang L, Jiang Z, Xiong Y, Chen H, Tao Y
Antimicrob Agents Chemother. 2011; 55(5):1930-6.
PMID: 21282436
PMC: 3088222.
DOI: 10.1128/AAC.01520-10.
In vitro mitochondrial toxicity of metacavir, a new nucleoside reverse transcriptase inhibitor for treatment of hepatitis B virus.
Zhang P, Zhang L, Jiang Z, Wang T, Chen H, Xiong Y
Antimicrob Agents Chemother. 2010; 54(11):4887-92.
PMID: 20805401
PMC: 2976109.
DOI: 10.1128/AAC.00794-10.
A transient kinetic approach to investigate nucleoside inhibitors of mitochondrial DNA polymerase gamma.
Anderson K
Methods. 2010; 51(4):392-8.
PMID: 20573564
PMC: 2916041.
DOI: 10.1016/j.ymeth.2010.05.001.
A mechanistic view of human mitochondrial DNA polymerase gamma: providing insight into drug toxicity and mitochondrial disease.
Bailey C, Anderson K
Biochim Biophys Acta. 2010; 1804(5):1213-22.
PMID: 20083238
PMC: 2846211.
DOI: 10.1016/j.bbapap.2010.01.007.
Imaging virus-associated cancer.
Fu D, Foss C, Nimmagadda S, Ambinder R, Pomper M
Curr Pharm Des. 2008; 14(28):3048-65.
PMID: 18991718
PMC: 3369625.
DOI: 10.2174/138161208786404371.
Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.
Fu D, Tanhehco Y, Chen J, Foss C, Fox J, Chong J
Nat Med. 2008; 14(10):1118-22.
PMID: 18776891
PMC: 2709824.
DOI: 10.1038/nm.1864.
Nonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis B.
Bridges E, Selden J, Luo S
Antimicrob Agents Chemother. 2008; 52(7):2521-8.
PMID: 18474576
PMC: 2443876.
DOI: 10.1128/AAC.00029-08.
Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition.
Mazzucco C, Hamatake R, Colonno R, Tenney D
Antimicrob Agents Chemother. 2007; 52(2):598-605.
PMID: 18056280
PMC: 2224751.
DOI: 10.1128/AAC.01122-07.
Comparison of [14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV for monitoring reporter gene expression of wild type and mutant herpes simplex virus type 1 thymidine kinase in cell culture.
Kang K, Min J, Chen X, Gambhir S
Mol Imaging Biol. 2005; 7(4):296-303.
PMID: 16041591
DOI: 10.1007/s11307-005-0010-7.
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial.
Jaboli M, Fabbri C, Liva S, Azzaroli F, Nigro G, Giovanelli S
World J Gastroenterol. 2003; 9(7):1491-5.
PMID: 12854148
PMC: 4615489.
DOI: 10.3748/wjg.v9.i7.1491.
Antiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues.
Stuyver L, Lostia S, Adams M, Mathew J, Pai B, Grier J
Antimicrob Agents Chemother. 2002; 46(12):3854-60.
PMID: 12435688
PMC: 132758.
DOI: 10.1128/AAC.46.12.3854-3860.2002.
Antiviral activities of MCC-478, a novel and specific inhibitor of hepatitis B virus.
Kamiya N, Kubota A, Iwase Y, Sekiya K, Ubasawa M, Yuasa S
Antimicrob Agents Chemother. 2002; 46(9):2872-7.
PMID: 12183240
PMC: 127398.
DOI: 10.1128/AAC.46.9.2872-2877.2002.
Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.
Birkus G, Hitchcock M, Cihlar T
Antimicrob Agents Chemother. 2002; 46(3):716-23.
PMID: 11850253
PMC: 127499.
DOI: 10.1128/AAC.46.3.716-723.2002.
Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism?.
Moyle G
Drug Saf. 2001; 23(6):467-81.
PMID: 11144657
DOI: 10.2165/00002018-200023060-00001.